Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits
A: Many clients feel a mild boost within 2448 hours, with more noticeable improvements in energy and focus over 13 weeks
Our skilled team ensures that you receive the right dosage and tailored care for your specific needs
Strong acids, oxidizers, and incompatible actives should be separated from AHK-Cu application as discussed in the formulation section
FDA does not review compounded medications for safety or efficacy
04 Let the solution dissolve without shaking